Tuesday, July 17, 2018

PreveCeutical seeing significant hospital interest for breakthrough Cannabidiol treatment

Stephen Van Deventer, chairman and CEO of PreveCeutical Medical Inc (CSE: PREV, OTCQB: PRVCF) and chief research officer Dr Harry Parekh discuss with Proactive the health sciences specialist's four exciting programmes.

Their most advanced is centred around Cannabidiol (CBD) - a non-psychoactive compound found in the cannabis plant and is now widely used to treat chronic pain, multiple sclerosis and other conditions.

Some evidence even suggests it can prevent symptoms of Alzheimer’s and appears to promote the death of cancer cells.

For more videos and content on this topic, visit https://sjaca.net

No comments:

Post a Comment

Background Music Composer - Compositions for your videos

Background music is an important and sometimes difficult aspect for video marketers. Having background music composed originally to suit you...